Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Sales | 3,710 | 3,979 | 3,613 | 7,420 | 2,640 |
| Gross Profit | 3,710 | 3,979 | 3,613 | 7,420 | 2,640 |
| Operating Expenses | 25,183 | 45,590 | 19,237 | 18,210 | 17,310 |
| Operating Income | -21,473 | -41,611 | -15,624 | -10,790 | -14,670 |
| Interest Expense | 5 | 10 | 2 | 4 | 10 |
| Other Income | 1,050 | 4,765 | 4,499 | 304 | -190 |
| Pre-tax Income | -20,428 | -36,856 | -11,127 | -10,490 | -14,870 |
| Income Tax | N/A | -462 | -287 | -330 | -190 |
| Net Income Continuous | -20,428 | -36,394 | -10,840 | -9,413 | -13,629 |
| Net Income | $-20,428 | $-36,394 | $-10,840 | $-10,150 | $-14,670 |
| EPS Basic Total Ops | -6.30 | -14.28 | -4.98 | -4.68 | -7.92 |
| EPS Basic Continuous Ops | -6.29 | -14.25 | -4.96 | -4.64 | -7.85 |
| EPS Diluted Total Ops | -6.30 | -14.28 | -4.98 | -4.68 | -7.92 |
| EPS Diluted Continuous Ops | -6.29 | -14.25 | -4.96 | -4.64 | -7.85 |
| EBITDA(a) | $-21,227 | $-41,364 | $-15,400 | $-10,450 | $-14,330 |